Literature DB >> 26124176

Alkaloids as inhibitors of malate synthase from Paracoccidioides spp.: receptor-ligand interaction-based virtual screening and molecular docking studies, antifungal activity, and the adhesion process.

Fausto Guimaraes Costa1, Benedito Rodrigues da Silva Neto2, Ricardo Lemes Gonçalves1, Roosevelt Alves da Silva1, Cecília Maria Alves de Oliveira3, Lucília Kato3, Carla Dos Santos Freitas3, Maria José Soares Mendes Giannini4, Julhiany de Fátima da Silva4, Célia Maria de Almeida Soares2, Maristela Pereira5.   

Abstract

Paracoccidioides is the agent of paracoccidioidomycosis. Malate synthase plays a crucial role in the pathogenicity and virulence of various fungi, such as those that are human pathogens. Thus, an inhibitor of this enzyme may be used as a powerful antifungal without side effects in patients once these enzymes are absent in humans. Here, we searched for compounds with inhibitory capacity against the malate synthase of Paracoccidioides species (PbMLS). The three-dimensional (3D) structure of PbMLS was determined using the I-TASSER server. Compounds were selected from the ZINC database. Based on the mechanism underlying the interaction of the compounds with PbMLS, it was possible to identify β-carboline moiety as a standard key structure. The compounds with β-carboline moiety that are available in our laboratories were investigated. A total of nine alkaloid compounds were selected. The primary mechanisms of interaction of the alkaloid compounds in the binding pocket of PbMLS were identified and compared with the mechanism of interaction of acetyl coenzyme A (acetyl-CoA). We discovered that the amphipathic nature of the compounds, concomitant with the presence of β-carboline moiety, was crucial for their stability in the binding pocket of PbMLS. In addition, the importance of a critical balance of the polar and nonpolar contacts of the compounds in this region was observed. Four β-carboline alkaloid compounds showed the ability to inhibit recombinant PbMLS (PbMLSr) activity, Paracoccidioides species growth, and adhesion of the fungus and PbMLSr to the extracellular matrix components. The cytotoxicity of the alkaloids was also evaluated.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26124176      PMCID: PMC4538557          DOI: 10.1128/AAC.04711-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Tools for comparative protein structure modeling and analysis.

Authors:  Narayanan Eswar; Bino John; Nebojsa Mirkovic; Andras Fiser; Valentin A Ilyin; Ursula Pieper; Ashley C Stuart; Marc A Marti-Renom; M S Madhusudhan; Bozidar Yerkovich; Andrej Sali
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

3.  Analyzing the topology of active sites: on the prediction of pockets and subpockets.

Authors:  Andrea Volkamer; Axel Griewel; Thomas Grombacher; Matthias Rarey
Journal:  J Chem Inf Model       Date:  2010-10-14       Impact factor: 4.956

4.  ZINC--a free database of commercially available compounds for virtual screening.

Authors:  John J Irwin; Brian K Shoichet
Journal:  J Chem Inf Model       Date:  2005 Jan-Feb       Impact factor: 4.956

5.  GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit.

Authors:  Sander Pronk; Szilárd Páll; Roland Schulz; Per Larsson; Pär Bjelkmar; Rossen Apostolov; Michael R Shirts; Jeremy C Smith; Peter M Kasson; David van der Spoel; Berk Hess; Erik Lindahl
Journal:  Bioinformatics       Date:  2013-02-13       Impact factor: 6.937

Review 6.  Virtual screening strategies in drug discovery: a critical review.

Authors:  A Lavecchia; C Di Giovanni
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

7.  Microplate alamarBlue assay for Paracoccidioides susceptibility testing.

Authors:  A C A de Paula e Silva; H C Oliveira; J F Silva; F Sangalli-Leite; L Scorzoni; A M Fusco-Almeida; M J S Mendes-Giannini
Journal:  J Clin Microbiol       Date:  2013-01-23       Impact factor: 5.948

Review 8.  Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis.

Authors:  M F Dunn; J A Ramírez-Trujillo; I Hernández-Lucas
Journal:  Microbiology       Date:  2009-08-14       Impact factor: 2.777

9.  Activity of novel non-amphipathic cationic antimicrobial peptides against Candida species.

Authors:  Lori L Burrows; Margareta Stark; Celine Chan; Evgenia Glukhov; Selva Sinnadurai; Charles M Deber
Journal:  J Antimicrob Chemother       Date:  2006-03-08       Impact factor: 5.790

10.  Inhibition of Paracoccidioides lutzii Pb01 isocitrate lyase by the natural compound argentilactone and its semi-synthetic derivatives.

Authors:  Renata Silva do Prado; Ricardo Justino Alves; Cecília Maria Alves de Oliveira; Lucília Kato; Roosevelt Alves da Silva; Guilherme Oliveira Quintino; Silvio do Desterro Cunha; Célia Maria de Almeida Soares; Maristela Pereira
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

View more
  7 in total

Review 1.  One Century of Study: What We Learned about Paracoccidioides and How This Pathogen Contributed to Advances in Antifungal Therapy.

Authors:  Erika Seki Kioshima; Patrícia de Souza Bonfim de Mendonça; Marcus de Melo Teixeira; Isis Regina Grenier Capoci; André Amaral; Franciele Abigail Vilugron Rodrigues-Vendramini; Bruna Lauton Simões; Ana Karina Rodrigues Abadio; Larissa Fernandes Matos; Maria Sueli Soares Felipe
Journal:  J Fungi (Basel)       Date:  2021-02-02

Review 2.  Antifungal Compounds against Candida Infections from Traditional Chinese Medicine.

Authors:  Xin Liu; Zhiming Ma; Jingxiao Zhang; Longfei Yang
Journal:  Biomed Res Int       Date:  2017-12-28       Impact factor: 3.411

3.  Antifungal activity of two oxadiazole compounds for the paracoccidioidomycosis treatment.

Authors:  Franciele Abigail Vilugron Rodrigues-Vendramini; Daniella Renata Faria; Glaucia Sayuri Arita; Isis Regina Grenier Capoci; Karina Mayumi Sakita; Silvana Martins Caparroz-Assef; Tania Cristina Alexandrino Becker; Patrícia de Souza Bonfim-Mendonça; Maria Sueli Felipe; Terezinha Inez Estivalet Svidzinski; Bernard Maigret; Érika Seki Kioshima
Journal:  PLoS Negl Trop Dis       Date:  2019-06-04

4.  Hepatitis C Virus NS3 Protease and Helicase Inhibitors from Red Sea Sponge (Amphimedon) Species in Green Synthesized Silver Nanoparticles Assisted by in Silico Modeling and Metabolic Profiling.

Authors:  Nourhan Hisham Shady; Amira R Khattab; Safwat Ahmed; Miaomiao Liu; Ronald J Quinn; Mostafa A Fouad; Mohamed Salah Kamel; Abdullatif Bin Muhsinah; Markus Krischke; Martin J Mueller; Usama Ramadan Abdelmohsen
Journal:  Int J Nanomedicine       Date:  2020-05-12

Review 5.  Overview of Antifungal Drugs against Paracoccidioidomycosis: How Do We Start, Where Are We, and Where Are We Going?

Authors:  Lívia do Carmo Silva; Amanda Alves de Oliveira; Dienny Rodrigues de Souza; Katheryne Lohany Barros Barbosa; Kleber Santiago Freitas E Silva; Marcos Antonio Batista Carvalho Júnior; Olívia Basso Rocha; Raisa Melo Lima; Thaynara Gonzaga Santos; Célia Maria de Almeida Soares; Maristela Pereira
Journal:  J Fungi (Basel)       Date:  2020-11-19

6.  Chemoproteomic identification of molecular targets of antifungal prototypes, thiosemicarbazide and a camphene derivative of thiosemicarbazide, in Paracoccidioides brasiliensis.

Authors:  Joyce Villa Verde Bastos Borba; Sinji Borges Ferreira Tauhata; Cecília Maria Alves de Oliveira; Monique Ferreira Marques; Alexandre Melo Bailão; Célia Maria de Almeida Soares; Maristela Pereira
Journal:  PLoS One       Date:  2018-08-27       Impact factor: 3.240

7.  Identification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1).

Authors:  Gabriela de Lima Menezes; Roosevelt Alves da Silva
Journal:  J Biomol Struct Dyn       Date:  2020-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.